Thomas Popeck Biography and Net Worth

CEO of Henry Schein

TOM POPECK has been with the Company since 2019, and in his current position as Chief Executive Officer of the Henry Schein Products Group since January 2025. He is also a member of our Executive Management Committee.

Mr. Popeck leads the Henry Schein Products Group, which includes all entities that design, manufacture, source, sell and market our own branded products, including our Global Oral Reconstruction Group (GORG) and our Healthcare Specialties Group (HSG). Prior to holding his current position, Mr. Popeck served as Chief Executive Officer, and prior to that, President, of our HSG, which included more than 20 business units operating in North America, South America, Europe and Asia.

Mr. Popeck has spent over two decades leading businesses in orthopedics and industrial manufacturing, including extensive experience in the medical device sector. Prior to joining the Company, Mr. Popeck held various sales leadership and general management executive positions, including leading Stryker’s Foot & Ankle business unit as Vice President and General Manager during his 11-year tenure with the company.

Mr. Popeck earned his Bachelor's in Engineering from Stevens Institute of Technology in Hoboken, NJ.

What is Thomas C. Popeck's net worth?: The estimated net worth of Thomas C. Popeck is at least $6.23 million as of March 19th, 2026. Mr. Popeck owns 86,182 shares of Henry Schein stock worth more than $6,225,615 as of March 22nd. This net worth approximation does not reflect any other investments that Mr. Popeck may own. Learn More about Thomas C. Popeck's net worth.
How do I contact Thomas C. Popeck?: The corporate mailing address for Mr. Popeck and other Henry Schein executives is 135 DURYEA RD, MELVILLE NY, 11747. Henry Schein can also be reached via phone at (631) 843-5500 and via email at [email protected]. Learn More on Thomas C. Popeck's contact information.
Has Thomas C. Popeck been buying or selling shares of Henry Schein?: During the last ninety days, Thomas C. Popeck has sold $98,630.45 of Henry Schein stock. Most recently, Thomas C. Popeck sold 1,355 shares of the business's stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $72.79, for a transaction totalling $98,630.45. Following the completion of the sale, the chief executive officer now directly owns 86,182 shares of the company's stock, valued at $6,273,187.78. Learn More on Thomas C. Popeck's trading history.
Who are Henry Schein's active insiders?: Henry Schein's insider roster includes Gerald Benjamin (EVP), Stanley Bergman (CEO), James Breslawski (Vice Chairman), David Brous, Jr. (CEO), Bradford Connett (CEO), Deborah Derby (Director), Michael Ettinger (SVP), Kurt Kuehn (Director), Philip Laskawy (Director), Lorelei McGlynn (SVP), Mark Mlotek (EVP), Steven Paladino (CFO), Thomas Popeck (CEO), Scott Serota (Director), and Walter Siegel (VP). Learn More on Henry Schein's active insiders.
Are insiders buying or selling shares of Henry Schein?: During the last year, insiders at the sold shares 7 times. They sold a total of 105,911 shares worth more than $8,574,981.71. The most recent insider tranaction occured on March, 19th when CEO Thomas C Popeck sold 1,355 shares worth more than $98,630.45. Insiders at Henry Schein own 1.1% of the company. Learn More about insider trades at Henry Schein.
Information on this page was last updated on 3/19/2026.

Thomas C. Popeck Insider Trading History at Henry Schein

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/19/2026	Sell	1,355	$72.79	$98,630.45	86,182

Thomas C. Popeck Buying and Selling Activity at Henry Schein

Henry Schein Company Overview

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Today's Range

Now: $72.24

$71.73

$73.36

50 Day Range

MA: $77.72

$72.24

$83.35

2 Week Range

Now: $72.24

$60.56

$89.29

Volume

1,313,906 shs

Average Volume

1,693,865 shs

Market Capitalization

$8.29 billion

P/E Ratio

22.09

Dividend Yield

N/A

Beta

0.88